Abbott Laboratories (ABT) Long-Term Investments (2009 - 2026)

Abbott Laboratories has disclosed Long-Term Investments across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $1.1 billion, up 20.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 20.18% YoY), and the FY2025 annual result was $918.0 million, up 3.61% from the prior year.
• Long-Term Investments came in at $1.1 billion for Q1 2026 at Abbott Laboratories, up from $918.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $1.1 billion in Q1 2026 to a low of $734.0 million in Q2 2022.
• The 5-year median for Long-Term Investments is $818.0 million (2024), against an average of $853.3 million.
• Across the five-year window, Long-Term Investments fell 8.82% in 2022 and advanced 20.18% in 2026, its largest moves.
• Abbott Laboratories' Long-Term Investments stood at $766.0 million in 2022, then increased by 4.31% to $799.0 million in 2023, then gained by 10.89% to $886.0 million in 2024, then increased by 3.61% to $918.0 million in 2025, then rose by 18.74% to $1.1 billion in 2026.
• The last three Long-Term Investments figures came in at $1.1 billion (Q1 2026), $918.0 million (Q4 2025), and $951.0 million (Q3 2025), per Business Quant data.